CHONDRAMIN CLASSIC (peptide bioregulator for cartilage tissue)

CHONDRAMIN® CLASSIC is recommended to facilitate recovery of carti­laginous tissue functions in case of inflammations and meta­bolic degeneration in the spine and joints, malnutrition, expo­sure to various extreme factors. Chondramin is also recom­mended to the elderly to support locomotor functions.

Chondramin is a nucleoprotein complex acting selectively on cartilaginous tissue cells promoting metabolic processes in cartilages and decreasing risk of various joint and spinal lesions.

Chondramin is a natural peptide bioregulator developed to restore and maintain the functions of the musculoskeletal system, cartilaginous tissue and the joints. It helps to eliminate impairments in the connective tissue and cartilages. Chondramin improves metabolism in chondrocytes, thus preventing the joints from pathological impairments and improves their functions. The peptides selectively act on the cells of the musculoskeletal system and improve its functions, thus accelerating the restoration of the joints and cartilages functions. Chondramin is recommended for elderly people to maintain the functions of the musculoskeletal system, to maintain the functions of joints and cartilages after heavy physical loads.

Chondramin is a complex of proteins and nucleoproteins obtained from the cartilages of young animals. The complex provides a selective action to the cells of the musculoskeletal system accelerating restoration processes and improving the functions of the joints and cartilages. After entering the body the peptides break down into amino acids and nucleoproteins, which are used by the cells of the joints to synthesize new essential proteins, thus producing new cells, restoring damaged cells, stimulating their growth and optimal functioning. The action of Chondramin relieves pain and increases movement in the affected joints; accelerates restoration of cartilage in inflammatory and metabolic-dystrophic lesions of joints and spinal column. Natural peptides do not cause side effects and intoxication, do not accumulate in the body and do not have withdrawal syndrome.

Usage:

• treat degenerative and dystrophic lesions of the joints and spinal column,
• combat arthropathy,
• cure systemic connective tissue diseases,
• before and after  joint surgery,
• care after heavy physical loads,
• prevent osteoarticular diseases in professional athletes.

Ingredients:

a complex of polypeptides and nucleic acids obtained from the cartilages of young animals - 10 mg; sucrose, potato starch, calcium stearate, methylcellulose, enteric coating

Dosage:

Chondramin is recommended to be administered 10-15 mi­nutes before meals 1-3 capsules or tablets 2-3 times a day for 10-15days.

Repeated course is advisable in 3-6months.

Form of release:

155mg/tab, 40 tabs

CYTAMINS® are unique blends of peptides, nucleic acids, vitamins, and minerals. They support the restoration of healthy tissue and organ function by working directly at the cellular level.

Peptides are organic molecules that influence a wide range of cellular activities in the body. Naturally occurring peptides help repair and regenerate the cells of specific organs, allowing them to maintain proper function even after treatment ends.

Bioregulation refers to the body’s ability to heal itself and maintain biochemical harmony, driven by its natural peptide network.

Bioregulatory peptides are short amino acid chains that control cellular metabolism, initiating processes like growth, differentiation, and repair.

Peptide therapy seeks to activate the body’s own regulatory systems by supplying peptides to organs and tissues.

This innovative approach represents the future of regenerative medicine, improving patients’ quality of life worldwide. CYTAMINS peptide bioregulators are compatible with any medication group and can be incorporated into virtually any treatment plan.

Guaranteed authenticity and quality:

100% Original from GEROPHARM (Russian Federation)

GEROPHARM is a national manufacturer of biotechnological products providing for medicinal safety of Russia. Development and production of medicinal products to treat socially important diseases as a fully integrated site. Implementation of the tasks in import substitution within state federal programs. Development of production of active pharmaceutical substances. Investment into technological development and creation of modern pharmaceutical infrastructure.

Development and production:

GEROPHARM (Russian Federation)

St. Petersburg Institute of Bioregulation and Gerontology